Co-Founder, Nimblegen Systems
October 1999 – Co-Founded NimbleGen Systems
NimbleGen Systems was founded to commercialize the Maskless Array Synthesizer (MAS) technology that Dr. Green co-invented as his thesis project. The MAS instrument used photochemistry to synthesize DNA on glass to make DNA microarrays
October 1999 to August 2007 – CTO and VP of R&D – NimbleGen Systems
Dr. Green was a founder and the first employee at NimbleGen Systems. He oversaw all technical development from the founding of the company until its acquisition by Roche for $272.5 million. He built and led the R&D team that developed the world’s leading high-density, long oligo microarrays using photochemical DNA synthesis on glass slides.
February 2004 to August 2007 – CTO and VP of R&D and Head of Manufacturing, Engineering, Quality Assurance Chemistry – NimbleGen Systems
In 2004 Dr. Green was given responsibility for managing all manufacturing operations, all engineering operations, all quality operations and all chemistry operations. At the time of the acquisition by Roche, Dr. Green had > 80 reports and managed 3 sites: Reykjavik, Iceland – Manufacturing; Waldkreiberg, Germany – Chemistry; and Madison, USA – R&D, Engineering and Quality Assurance.
March 2008 – Founder, CEO and President – GreenStone Technologies
In March 2008, Dr. Green founded GreenStone Technologies to develop dye sensitized solar cells (DSSCs). His experience at NimbleGen with photochemistry on glass surfaces and his product development experience moving technology from the laboratory to commercial products while managing interdisciplinary teams make him particularly well suited for the task of commercializing the DSSC technology.